Pharmacokinetic Study of Oxidized Dextrans

A. A. Starostenko; A. V. Troitskii; V. S. Medvedev; E. P. Gulyaeva; T. N. Bystrova; V. A. Shkurupii

doi:10.1007/s11094-016-1373-6

Pharmacokinetic Study of Oxidized Dextrans

Авторлар: Starostenko A.A.¹, Troitskii A.V.¹, Medvedev V.S.¹, Gulyaeva E.P.¹, Bystrova T.N.¹, Shkurupii V.A.¹
Мекемелер:
1. Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences
Шығарылым: Том 49, № 12 (2016)
Беттер: 795-797
Бөлім: Molecular-Biological Problems of Drug Design and Mechanism of Drug Action
URL: https://ogarev-online.ru/0091-150X/article/view/244294
DOI: https://doi.org/10.1007/s11094-016-1373-6
ID: 244294

Дәйексөз келтіру

Толық мәтін

Ашық рұқсат
Рұқсат жабық

Рұқсат берілді
Рұқсат жабық

Тек жазылушылар үшін

Аннотация
Авторлар туралы
Әдебиет тізімі
Қосымша файлдар
Статистика

Аннотация

Methods of obtaining biotinylated oxidized dextran (BTOD) and procedures for pharmacokinetic studies of BTOD and biotinylated dextran (BTD) are described. The pharmacokinetics results showed that there are no differences in principle between the oxidized and unoxidized dextrans. All studied dextrans were characterized by two-phase pharmacokinetic profiles after intraperitoneal and subcutaneous administration.

Негізгі сөздер

oxidized dextran, pharmacokinetics, biotin, immunoenzymatic assay

Авторлар туралы

A. Starostenko

Institute of Experimental and Clinical Medicine, Siberian Branch, Russian Academy of Medical Sciences